This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Dexcom, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Adam Noar - Innovator in Glucose Monitoring Technology
Introduction
Adam Noar is an accomplished inventor based in San Diego, CA. He has made significant contributions to the field of glucose monitoring through his innovative patent. His work focuses on enhancing user interfaces for glucose insight presentation, which is crucial for individuals managing their glucose levels.
Latest Patents
Adam Noar holds a patent for "User interfaces for glucose insight presentation." This patent involves a glucose monitoring application that processes glucose measurements to derive insights about a user's glucose levels. The application is designed to collect glucose measurements at predetermined intervals, such as every five minutes, from a glucose monitoring device. The user interface is configured to present visual elements that represent these insights, including color fields that indicate whether the user's current glucose measurement falls below, within, or above a specified range.
Career Highlights
Adam Noar is currently employed at Dexcom, Inc., a leading company in glucose monitoring technology. His role involves developing innovative solutions that improve the user experience for individuals relying on glucose monitoring devices. His patent reflects his commitment to advancing technology in this critical area of health management.
Collaborations
Some of Adam's coworkers include Alexander Michael Diener and Stacey Fischer. Their collaboration contributes to the innovative environment at Dexcom, Inc., fostering advancements in glucose monitoring technology.
Conclusion
Adam Noar's contributions to glucose monitoring technology through his patent demonstrate his dedication to improving health management solutions. His work at Dexcom, Inc. continues to influence the way users interact with glucose monitoring applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
